logo
Share SHARE
FONT-SIZE Plus   Neg

Merck, GE Healthcare Collaborate For BACE Inhibitor Development Program

Merck (MRK), known as MSD outside the U.S. and Canada, and GE Healthcare, an unit of General Electric Co. (GE), announced a study collaboration, license and supply agreement for use of [18F]Flutemetamol, an investigational positron emission tomography or PET imaging agent, to support Merck's development of MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme or BACE inhibitor and Merck's lead investigational candidate for Alzheimer's disease.

According to the agreement, GE Healthcare would supply [18F]Flutemetamol to help select patients for trials and assess this investigational agent as a companion diagnostic tool. A joint Merck and GE Healthcare Imaging Advisory Committee would oversee the planned imaging studies.

"In clinical trials, [18F]Flutemetamol demonstrated consistent performance in the visual detection of beta amyloid in the brain when compared with histopathology data," according to Jonathan Allis, general manager, PET, GE Healthcare Medical Diagnostics.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Maternity leave is a temporary period of absence from employment granted to expectant or new mothers during the months immediately before and after their pregnancy. Parental leave, including maternity, paternity and adoption leave, is an employee benefit. Many countries around the world, including... Texas, the second largest state in the U.S., has four of the five fastest-growing cities in the U.S., according to new population estimates released Thursday by the U.S. Census Bureau for the twelve months up to July 1, 2016. Ten of the fifteen fastest growing large U.S. cities during that 12-month span were in the South, according to the Census Bureau. To book-lover's surprise, online retailer Amazon opened another bricks and mortar store in an upmarket shopping mall in New York. This is the seventh book store of Amazon.
comments powered by Disqus
Follow RTT